Clinical Trial Update: Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating half-dose prasugrel and ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Dong-A University | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED